Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema (left eye)
ICD-10 E09.3392 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema (left eye).
E09.3392 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by moderate nonproliferative diabetic retinopathy in the left eye without macular edema. This condition arises when certain medications or substances lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. The presence of moderate nonproliferative diabetic retinopathy indicates that there are changes in the retinal blood vessels, which can lead to vision impairment if not managed properly. The absence of macular edema suggests that the central part of the retina is not swollen, which is a more severe complication. Management of this condition typically involves controlling blood glucose levels through lifestyle modifications, monitoring HbA1c levels, and possibly insulin therapy, depending on the severity of the diabetes. Regular eye examinations are crucial to monitor the progression of retinopathy and to prevent further complications.
Detailed history of diabetes management, including medications and HbA1c levels.
Patients with drug-induced diabetes requiring insulin therapy.
Ensure clear documentation of the drug responsible for diabetes.
Comprehensive eye examination reports detailing retinopathy findings.
Patients presenting with vision changes due to diabetic retinopathy.
Document the absence of macular edema and specify eye involvement.
Used during routine eye exams for diabetic retinopathy.
Document findings of retinopathy and any treatment plans.
Ophthalmologists should ensure detailed documentation of eye health.
Medications such as corticosteroids, certain antipsychotics, and some antiretrovirals are known to induce diabetes by affecting insulin sensitivity or secretion.
